Delivery Order SPE2DB20D3104-SPE2DB25FV8N1
Award Date 6/26/25
Potential Completion Date 6/27/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $14,473.05 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. The contract, awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,978.28 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 10, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,134.56 for 60-tablet units of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia treatment. This competitively awarded, firm fixed-price delivery order was established on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract includes no set-aside designation,...
- The Defense Logistics Agency awarded a $1,718.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. The award, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. This delivery order was competitively awarded with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $46,648.43 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac care. The contract is a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and was awarded on September 8, 2025. This award carries no set-aside designation, indicating it was competitively awarded through open procurement processes. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,110.62 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on June 25, 2025, with completion expected by June 26, 2025. This competitively awarded contract, issued without set-aside designation, represents a firm fixed price delivery order for pharmaceutical supply to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $7,054.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. The contract was competitively awarded without set-aside provisions and is scheduled for completion by June 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, which represents a continuation of the company's...
- The Defense Logistics Agency awarded a $18,713.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia treatment. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across...
- The Defense Logistics Agency awarded a delivery order valued at $25,419.82 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on September 16, 2025, with completion expected by September 17, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for a brand-name cardiac arrhythmia medication. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,167.80 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia treatment. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 15, 2025. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...